China's State Food and Drug Administration (SFDA) are scrutinizing a drug, named Shuanghuanglian, which is the product of Duoduo Pharmaceutcal Company, Ltd. in Heilongjiang. The drug regulators are suspicious that this herbal injection might be the reason behind three deaths that occurred in three different provinces of country.
SFDA, in association with China's Ministry of health, has deputed an investigation team to probe this case.